Mandate

Vinge advises Cellink in conjunction with the acquisition of Scienion Ag

Vinge has advised Cellink AB, listed on Nasdaq Stockholm, in connection with the acquisition of all shares in Scienion Ag. Scienion is a life science company which focuses on precision dimensioning technology.

The Scienion group conducts operations in Germany, the United States, France and England. The purchase price for the shares, on a cash‑free and debt‑free basis, amounts to EUR 80 million, of which EUR 40 million is paid in cash and the remaining EUR 40 million is paid in newly issued Cellink shares. Closing is expected to take place at the end of August whereupon Cellink’s board of directors will adopt a resolution concerning the issue in kind in accordance with the authorization resolved at the company’s general meeting. Cellink intends to perform a new issue of shares in order to finance the cash element of the purchase price.

Vinge’s team has consisted of, among others, Anders StridMartin E Svanberg (M&A), Edin Agic (Capital Markets) as well as Anna Palmérus (Competition Law). Hengeler Mueller advised Cellink in Germany.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025